EUVIMEDEUVIMED entdecken
Open Access

Assessment of Severity of Long QT Syndrome Phenotype and Risk of Fetal Death

Lisa Albertini iD, Jordan Ezekian iD, Melanie Care, Candice Silversides, Mathew Sermer, Michael H Gollob iD, Danna Spears iD

Journal of the American Heart Association · 2023

DOI: 10.1161/jaha.122.029407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Lisa Albertini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Electrophysiology, Toronto General Hospital University Health Network Toronto Toronto Ontario Canada. Hauptthemen laut MEDLINE: Long QT Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background It has been postulated that long QT syndrome (LQTS) can cause fetal loss through putative adverse effects of the channelopathy on placenta and myometrial function. The authors aimed to describe the fetal death rate in a population of pregnant women with long QT syndrome and investigate whether women with more severe phenotype had worse fetal outcomes. Methods and Results The authors retrospectively evaluated fetal outcomes of 64 pregnancies from 23 women with long QT syndrome followed during pregnancy in a tertiary pregnancy and heart disease program. Thirteen of 64 pregnancies (20%) resulted in a fetal loss, 12 miscarriages (19%), and 1 stillbirth (1.6%). Baseline maternal characteristics, including age and use of β‐blockers, did not differ between women who experienced a fetal death or not. Maternal corrected QT interval (QTc) was significantly longer in pregnancies that resulted in fetal death compared with live births (median, 518 ms [interquartile range (IQR), 482‐519 ms] versus 479 ms [IQR, 454–496 ms], P 500 ms was significantly lower compared with women with QTc 500 ms is lower, suggesting that patients with more marked phenotype may experience worse fetal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Long QT SyndromeHumansFemalePregnancyBirth WeightRetrospective StudiesFetal DeathPhenotypeAdrenergic beta-AntagonistsElectrocardiography

Stichwörter der Autor:innen

fetal deathlong QTlong QT syndromemiscarriagestillbirth

Substanzen

Adrenergic beta-Antagonists

Autor:innen und Institutionen

  • Division of Cardiology, Electrophysiology, Toronto General Hospital University Health Network Toronto Toronto Ontario Canada.
  • Division of Cardiology The Hospital for Sick Children Toronto Ontario Canada.
  • Department of Medicine, Division of Cardiology University of Toronto Pregnancy and Heart Disease Program and Obstetric Medicine Program, Mount Sinai and Toronto General Hospitals Toronto Ontario Canada.
  • Department of Obstetrics and Gynaecology Mount Sinai Hospital Toronto Ontario Canada.

ORCID-Profile: Lisa Albertini, Jordan Ezekian, Michael H Gollob, Danna Spears

Zitieren

APA

Albertini, L., Ezekian, J., Care, M., Silversides, C., Sermer, M., Gollob, M. H., & Spears, D. (2023). Assessment of Severity of Long QT Syndrome Phenotype and Risk of Fetal Death. Journal of the American Heart Association. https://doi.org/10.1161/jaha.122.029407

Vancouver

Albertini L, Ezekian J, Care M, Silversides C, Sermer M, Gollob MH, et al. Assessment of Severity of Long QT Syndrome Phenotype and Risk of Fetal Death. Journal of the American Heart Association. 2023. doi:10.1161/jaha.122.029407

BibTeX
@article{Albertini2023,
  author = {Albertini, Lisa and Ezekian, Jordan and Care, Melanie and Silversides, Candice and Sermer, Mathew and Gollob, Michael H and Spears, Danna},
  title = {Assessment of Severity of Long QT Syndrome Phenotype and Risk of Fetal Death},
  journal = {Journal of the American Heart Association},
  year = {2023},
  doi = {10.1161/jaha.122.029407}
}
Kostenlos starten →